The Problem With Standard TRT for Some Men
Conventional testosterone replacement therapy — injectable testosterone or testosterone gel — works by replacing testosterone from an external source. It's effective for raising testosterone and resolving symptoms of hypogonadism. But it comes with a specific trade-off: it shuts down your body's own testosterone production.
When exogenous testosterone enters the bloodstream, the hypothalamus detects it and reduces its GnRH signal. The pituitary responds by reducing LH and FSH. The testes, no longer receiving the LH signal to produce testosterone, reduce and eventually halt their own production. Testicular atrophy follows over months.
For men with primary hypogonadism (testes that can't produce adequate testosterone regardless of signalling) this trade-off is irrelevant — the testes weren't working properly anyway. But for men with secondary hypogonadism — where the pituitary or hypothalamus isn't sending the right signals, but the testes themselves are capable of producing testosterone — there is an alternative approach: stimulate the body's own system rather than replacing it.
That's what enclomiphene does.
What Enclomiphene Is
Enclomiphene is a selective oestrogen receptor modulator (SERM) — specifically, it blocks oestrogen receptors in the hypothalamus and pituitary. When oestrogen can't signal to these areas, the feedback mechanism that suppresses GnRH and LH is blocked. The hypothalamus increases GnRH output. The pituitary increases LH and FSH. The testes respond by producing more testosterone.
In simple terms: enclomiphene tricks the hypothalamus into thinking oestrogen is low, which causes it to push harder on the testosterone production signal.
Enclomiphene vs. clomiphene (Clomid): This is where it gets important. Clomiphene (Clomid) is the older SERM most doctors know. It comes in two isomers: enclomiphene (the trans isomer) and zuclomiphene (the cis isomer). Standard clomiphene tablets contain both.
The problem with zuclomiphene: it has weak oestrogenic activity. It partially acts as an oestrogen agonist in some tissues, which can cause side effects including mood disturbance, vision changes, and emotional instability — the side effects most commonly reported with standard Clomid in men.
Enclomiphene is the isomer that does the useful work. Enclomiphene on its own — without zuclomiphene — produces the LH and testosterone stimulation without the oestrogenic side effects of the mixed isomer product. It's a cleaner compound with a better tolerability profile.
What the Research Shows
Multiple studies have evaluated enclomiphene in men with secondary hypogonadism:
Testosterone increases: Studies consistently show total testosterone increases to normal or above-normal ranges in men with secondary hypogonadism. A Phase II trial showed mean testosterone increases from approximately 8–10 nmol/L to 18–22 nmol/L — within or above the functional normal range.
LH and FSH preserved: Unlike TRT, which suppresses LH and FSH, enclomiphene increases them. Sperm production is maintained or improved (fertility preserved).
Testicular function maintained: Because LH signalling is intact, the testes continue to function. Testicular volume is maintained on enclomiphene vs. the atrophy seen with TRT.
Regulatory status: Enclomiphene (brand name Androxal) failed to receive FDA approval for secondary hypogonadism despite promising Phase III data — the FDA requested additional studies that Repros Therapeutics (the developer) chose not to pursue. It is prescribed off-label in the UK and US by private clinics as an alternative to TRT.
Who Enclomiphene Is For
Best candidates:
Men with confirmed secondary hypogonadism — Low testosterone with low or inappropriately normal LH and FSH. The pituitary isn't signalling properly, but the testes can still respond. Enclomiphene addresses the signalling deficit directly.
Men who want to preserve fertility on treatment — TRT suppresses sperm production. Enclomiphene maintains LH and FSH, preserving the testicular function required for fertility. For men who want testosterone optimisation while keeping the option of conception open, enclomiphene is the first-line consideration.
Men who are not ready for lifelong TRT — TRT is a long-term commitment. Stopping TRT without a proper restart protocol causes a significant testosterone crash. Enclomiphene can be stopped more cleanly — the natural production mechanism was never suppressed.
Younger men (20s–30s) with low testosterone — The implications of lifelong TRT started early are more significant. Enclomiphene may provide a period of normalised testosterone while preserving options.
Not appropriate for:
Primary hypogonadism — If the testes themselves are damaged or dysfunctional (Klinefelter's syndrome, post-chemotherapy, testicular injury), stimulating the signalling axis won't help. The testes can't respond.
Men with very low testosterone who need reliable, consistent elevation — Enclomiphene produces testosterone increases but individual response varies more than with injectable TRT. Men who need precise, consistent levels (e.g., in athletic or performance contexts) typically prefer the predictability of injectable testosterone.
Enclomiphene in UK Clinical Practice
Enclomiphene is not licensed as a medication in the UK for testosterone deficiency. It is prescribed off-label by private TRT and men's health clinics — the same clinics that provide TRT (Optimale, Balance My Hormones, Leger) often have enclomiphene as a protocol option.
The typical prescription:
- 12.5–25mg daily, oral tablet
- Bloodwork at 6–8 weeks to check testosterone, LH, FSH, oestradiol
- Dose adjustment based on results and symptoms
Sourcing outside a clinical setting is complicated — enclomiphene is not widely available as a research chemical in the same way peptides are. The reliable route is through a private clinic prescription.
The Hormonal Picture on Enclomiphene vs. TRT
| | TRT (injectable) | Enclomiphene | |---|---|---| | Total testosterone | Rises (exogenous) | Rises (endogenous) | | LH | Suppressed | Elevated | | FSH | Suppressed | Elevated | | Sperm production | Suppressed | Maintained or improved | | Testicular volume | Declines over time | Maintained | | Oestradiol | May rise (aromatase from T) | Modestly managed (SERM blocks receptor) | | Stopping protocol | Requires restart (HCG/clomid) | Relatively clean discontinuation | | Consistency | High and predictable | Variable by individual |
Side Effects and Monitoring
Oestradiol: Enclomiphene blocks oestrogen receptors in the hypothalamus/pituitary but not in other tissues. Oestrogen levels in blood may rise slightly (due to increased testosterone substrate for aromatase). Unlike standard Clomid, enclomiphene is less likely to cause vision changes or emotional instability. If oestradiol rises significantly, aromatase inhibitor support may be needed.
Visual symptoms: Associated primarily with zuclomiphene (the other isomer in standard Clomid). Should be minimal or absent with pure enclomiphene, but worth monitoring.
Mood: Some men report mood improvements as testosterone normalises. The emotional destabilisation sometimes reported with standard Clomid (due to zuclomiphene's partial oestrogen agonist activity) should not occur with pure enclomiphene.
Blood markers to monitor: Testosterone, LH, FSH, oestradiol, haematocrit. At 6–8 weeks post-initiation and every 3–6 months thereafter.
Enclomiphene vs. TRT: Which to Choose?
The right choice depends on the clinical picture:
Choose TRT if:
- Primary hypogonadism (testes can't respond)
- Low testosterone with high LH already (testes aren't responding to the signal)
- Desire for consistent, predictable testosterone levels
- Fertility is not a current concern
- Previous enclomiphene trial has shown inadequate response
Consider enclomiphene first if:
- Secondary hypogonadism with evidence that the testes can respond
- Fertility preservation is a priority
- Preference for maintaining natural testosterone production
- Want to trial a less permanent intervention before committing to TRT
- Younger men where the implications of long-term TRT are greater
The combination approach: Some protocols use HCG (which mimics LH, maintaining testicular function) alongside TRT to get the benefits of both. Enclomiphene is an alternative route to preserving testicular function — different mechanism, similar goal.
The Short Version
Enclomiphene is a SERM that stimulates the body's own testosterone production rather than replacing it externally. It's the cleaner isomer of clomiphene, without the side effects of standard Clomid. Testosterone rises, LH and FSH are maintained, fertility is preserved. Best for secondary hypogonadism where the testes can still respond, and for men who want to maintain natural production or preserve fertility. Prescribed off-label by UK private clinics. Not a substitute for TRT where primary hypogonadism is the issue, but a genuinely different and often preferable option for the right candidate.